Koda M - Search Results

1

Hepatitis B and C virus infection is a risk factor for the development of cholangiocarcinoma.

Matsumoto K, Onoyama T, Kawata S, Takeda Y, Harada K, Ikebuchi Y, Ueki M, Miura N, Yashima K, Koda M, Sakamoto T, Endo M, Horie Y, Murawaki Y. Matsumoto K, et al. Among authors: koda m. Intern Med. 2014;53(7):651-4. doi: 10.2169/internalmedicine.53.1410. Epub 2012 Mar 1. Intern Med. 2014. PMID: 24694471 Free article.

2

[A case of gastrointestinal stromal tumor of the duodenum with increased color flow signals].

Maeda N, Mitsuda A, Koda M, Koda M, Hosoda A, Shiota G, Murawaki Y, Suou T, Kawasaki H. Maeda N, et al. Among authors: koda m. Nihon Shokakibyo Gakkai Zasshi. 2002 Jul;99(7):820-7. Nihon Shokakibyo Gakkai Zasshi. 2002. PMID: 12170712 Review. Japanese. No abstract available.

3

The proMMP-2 activation rate in patients with chronic viral liver disease.

Murawaki Y, Ikuta Y, Koda M, Okamoto K, Mimura K. Murawaki Y, et al. Among authors: koda m. Clin Chim Acta. 2002 Oct;324(1-2):99-103. doi: 10.1016/s0009-8981(02)00239-5. Clin Chim Acta. 2002. PMID: 12204430

4

Diaphragmatic perforation and hernia after hepatic radiofrequency ablation.

Koda M, Ueki M, Maeda N, Murawaki Y. Koda M, et al. AJR Am J Roentgenol. 2003 Jun;180(6):1561-2. doi: 10.2214/ajr.180.6.1801561. AJR Am J Roentgenol. 2003. PMID: 12760919 No abstract available.

5

Hepatocellular carcinoma with sarcomatous change arising after radiofrequency ablation for well-differentiated hepatocellular carcinoma.

Koda M, Maeda Y, Matsunaga Y, Mimura K, Murawaki Y, Horie Y. Koda M, et al. Hepatol Res. 2003 Oct;27(2):163-167. doi: 10.1016/s1386-6346(03)00207-9. Hepatol Res. 2003. PMID: 14563432

6

Qualitative assessment of tumor vascularity in hepatocellular carcinoma by contrast-enhanced coded ultrasound: comparison with arterial phase of dynamic CT and conventional color/power Doppler ultrasound.

Koda M, Matsunaga Y, Ueki M, Maeda Y, Mimura K, Okamoto K, Hosho K, Murawaki Y. Koda M, et al. Eur Radiol. 2004 Jun;14(6):1100-8. doi: 10.1007/s00330-003-2172-5. Epub 2003 Dec 16. Eur Radiol. 2004. PMID: 14676975

7

The influence on liver parenchymal function and complications of radiofrequency ablation or the combination with transcatheter arterial embolization for hepatocellular carcinoma.

Koda M, Ueki M, Maeda Y, Mimura KI, Okamoto K, Matsunaga Y, Kawakami M, Hosho K, Murawaki Y. Koda M, et al. Hepatol Res. 2004 May;29(1):18-23. doi: 10.1016/j.hepres.2004.02.001. Hepatol Res. 2004. PMID: 15135342

8

Percutaneous sonographically guided radiofrequency ablation with artificial pleural effusion for hepatocellular carcinoma located under the diaphragm.

Koda M, Ueki M, Maeda Y, Mimura K, Okamoto K, Matsunaga Y, Kawakami M, Hosho K, Murawaki Y. Koda M, et al. AJR Am J Roentgenol. 2004 Sep;183(3):583-8. doi: 10.2214/ajr.183.3.1830583. AJR Am J Roentgenol. 2004. PMID: 15333339 Clinical Trial.

9

[Methylhistidine].

Koda M, Murawaki Y. Koda M, et al. Nihon Rinsho. 2004 Nov;62 Suppl 11:603-5. Nihon Rinsho. 2004. PMID: 15628487 Japanese. No abstract available.

10

Sonographic subcutaneous and visceral fat indices represent the distribution of body fat volume.

Koda M, Senda M, Kamba M, Kimura K, Murawaki Y. Koda M, et al. Abdom Imaging. 2007 May-Jun;32(3):387-92. doi: 10.1007/s00261-006-9082-3. Epub 2006 Sep 1. Abdom Imaging. 2007. PMID: 16947071

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

795 results

Search Page

Filters